141 related articles for article (PubMed ID: 41876)
1. Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
Goldsmith LA; Thorpe J; Roe CR
J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876
[TBL] [Abstract][Full Text] [Related]
2. Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
al-Hemidan AI; al-Hazzaa SA
Ophthalmic Genet; 1995 Mar; 16(1):21-6. PubMed ID: 7648039
[TBL] [Abstract][Full Text] [Related]
3. Richner-Hanhart syndrome and tyrosinemia type II.
Hunziker N
Dermatologica; 1980; 160(3):180-9. PubMed ID: 6446465
[TBL] [Abstract][Full Text] [Related]
4. [A case of Richner-Hanhart syndrome (tyrosinosis with ocular, cutaneous and mental manifestations].
Goddé-Jolly D; Larregue M; Roussat B; Van Effenterre G
J Fr Ophtalmol; 1979 Jan; 2(1):23-8. PubMed ID: 34642
[TBL] [Abstract][Full Text] [Related]
5. Painful keratoderma and photophobia: hallmarks of tyrosinemia type II.
Rabinowitz LG; Williams LR; Anderson CE; Mazur A; Kaplan P
J Pediatr; 1995 Feb; 126(2):266-9. PubMed ID: 7844676
[TBL] [Abstract][Full Text] [Related]
6. [Richner-Hanhart syndrome (tyrosinemia II)].
Piccinno R; Menni S; Ermacora E; Cantoro M
G Ital Dermatol Venereol; 1985; 120(3):165-8. PubMed ID: 3161818
[No Abstract] [Full Text] [Related]
7. Tyrosinemia type II in two cases previously reported as Richner-Hanhart syndrome.
Balato N; Cusano F; Lembo G; Santoianni P
Dermatologica; 1986; 173(2):66-74. PubMed ID: 2947825
[TBL] [Abstract][Full Text] [Related]
8. Richner-Hanhart syndrome detected by expanded newborn screening.
Meissner T; Betz RC; Pasternack SM; Eigelshoven S; Ruzicka T; Kruse R; Laitenberger G; Mayatepek E
Pediatr Dermatol; 2008; 25(3):378-80. PubMed ID: 18577048
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinemia type II (Richner-Hanhart syndrome): a new mutation in the TAT gene.
Culic V; Betz RC; Refke M; Fumic K; Pavelic J
Eur J Med Genet; 2011; 54(3):205-8. PubMed ID: 21145993
[TBL] [Abstract][Full Text] [Related]
10. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
Paige DG; Clayton P; Bowron A; Harper JI
J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
[No Abstract] [Full Text] [Related]
11. Successful dietary control of tyrosinemia II.
Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H
J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
[TBL] [Abstract][Full Text] [Related]
12. Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II).
Sayar RB; von Domarus D; Schäfer HJ; Beckenkamp G
Ophthalmologica; 1988; 197(1):1-6. PubMed ID: 3054681
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
Goldsmith LA
Exp Cell Biol; 1978; 46(1-2):96-113. PubMed ID: 23331
[TBL] [Abstract][Full Text] [Related]
14. Familial richner-Hanhart syndrome in Kuwait: twelve-year clinical reassessment by a multidisciplinary approach.
el-Badramany MH; Fawzy AR; Farag TI
Am J Med Genet; 1995 Oct; 60(5):353-5. PubMed ID: 8546145
[No Abstract] [Full Text] [Related]
15. Pseudodendritic keratitis and systemic tyrosinemia.
Charlton KH; Binder PS; Wozniak L; Digby DJ
Ophthalmology; 1981 Apr; 88(4):355-60. PubMed ID: 6454871
[TBL] [Abstract][Full Text] [Related]
16. [4 cases of Richner-Hanhart syndrome (tyrosinemia type II) with neurological symptomatology in a Yugoslav family].
Salamon T; Hrnjica M; Schnyder UW; Lazović O; Softić M; Topić B; Stolić V; Popović N; Cerkez A; Basić V
Hautarzt; 1988 Mar; 39(3):149-54. PubMed ID: 2967808
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
Pelet B; Antener I; Faggioni R; Spahr A; Gautier E
Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708
[TBL] [Abstract][Full Text] [Related]
18. [Tyrosinemia and Richner-Hanhart syndrome (an autosomal recessive hereditary metabolic disease of childhood with bilateral dendritic pseudokeratitis, keratosis palmaris et plantaris and mental deficiency)].
Jaeger W; Gallasch G; Schnyder UW; Lutz P; Schmidt H
Ber Zusammenkunft Dtsch Ophthalmol Ges; 1978; (75):649-54. PubMed ID: 154319
[No Abstract] [Full Text] [Related]
19. Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.
Natt E; Kida K; Odievre M; Di Rocco M; Scherer G
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9297-301. PubMed ID: 1357662
[TBL] [Abstract][Full Text] [Related]
20. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
Andersson S; Nemeth A; Ohisalo J; Strandvik B
Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
